Semaglutide Better Than Liraglutide for Post-Bariatric Surgery Weight Recurrence
WEDNESDAY, June 7, 2023 (HealthDay News) -- Semaglutide is associated with superior weight loss for treating post-metabolic and bariatric surgery (MBS) weight recurrence compared with liraglutide, according to a study published in the May issue of Obesity.
Natia Murvelashvili, M.D., from UT Southwestern Medical Center in Dallas, and colleagues compared the effectiveness of weekly semaglutide versus daily liraglutide for treating post-MBS weight recurrence in a retrospective study. The analysis included 207 adults with post-MBS weight recurrence treated with weekly semaglutide (115 individuals) or daily liraglutide (92 individuals).
The researchers report that the least-squares mean weight change at 12 months was −12.92 percent in the semaglutide group versus −8.77 percent in the liraglutide group. The odds of ≥10 and ≥15 percent weight loss over 12 months were higher in the semaglutide group versus the liraglutide group (adjusted odds ratios, 2.34 and 2.55, respectively). There were no differences seen in the effectiveness of semaglutide versus liraglutide by the subgroups analyzed, including age, sex, and bariatric procedure type.
"A strength of this study is that these real-world data reflect weight-loss outcomes achieved under circumstances of everyday clinical care in a population seeking treatment for post-MBS weight recurrence," the authors write.
Several authors disclosed ties to pharmaceutical companies, including Novo Nordisk, the manufacturer of semaglutide.
Related Posts
¿Quiénes son los nuevos ‘influentes de pacientes’ en las redes sociales?
VIERNES, 15 de abril de 2022 (HealthDay News) -- Gem Hubbard, una activista de...
Un medicamento podría ser una alternativa para tratar las ITU sin antibióticos
VIERNES, 11 de marzo de 2022 (HealthDay News) -- Es común que las mujeres que...
Menstrual Bleeding Changes Reported After COVID-19 Vaccination
FRIDAY, July 15, 2022 (HealthDay News) -- Changes to menstrual bleeding patterns...
Women Give High Marks to Breast Reconstruction Using Patient’s Own Tissue
TUESDAY, Oct. 3, 2023 (HealthDay News) – Women who have breast reconstruction...